Showing metabocard for Cembrene (MMDBc0060745)
Microbial
| Record Information | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Version | 1.0 | ||||||||||||
| Status | Detected and Quantified | ||||||||||||
| Creation Date | 2025-10-02 22:34:23 UTC | ||||||||||||
| Update Date | 2025-10-08 21:35:18 UTC | ||||||||||||
| Metabolite ID | MMDBc0060745 | ||||||||||||
| Metabolite Identification | |||||||||||||
| Common Name | Cembrene | ||||||||||||
| Description | Cembrene is a diterpene, a class of chemical compounds characterized by a molecular structure that consists of four isoprene units. This compound is involved in various biosynthetic pathways, notably in the production of cembrene-type diterpenes from geranylgeranyl diphosphate (GGPP) through the action of specific enzymes like SpTS1, which exhibits substrate promiscuity (PMID:41027039 ). Cembrene A, a notable variant, has been identified in essential oils, where it coexists with other terpenes like (Z,E)-α-farnesene (PMID:40638914 ). Molecular docking studies indicate that cembrene A interacts with key bacterial proteins, including dihydrofolate reductase (DHFR) and DNA gyrase, suggesting potential roles in microbial pathways (PMID:40638914 ). Furthermore, the biosynthesis of cembrene B γ-lactone has been successfully reconstituted in heterologous hosts, highlighting its structural significance within the briarane diterpenoid family (PMID:40514549 ). Additionally, cembrene levels are influenced by genetic modifications in plants, as seen in transgenic tobacco, where key floral terpenes, including cembrene, are significantly increased (PMID:39256664 ). Overall, cembrene and its derivatives represent a complex interplay of chemistry and biology, with implications for both natural product synthesis and potential therapeutic applications. | ||||||||||||
| Structure |  | ||||||||||||
| Synonyms | Not Available | ||||||||||||
| Molecular Formula | C20H32 | ||||||||||||
| Average Mass | 272.476 | ||||||||||||
| Monoisotopic Mass | 272.25040103 | ||||||||||||
| IUPAC Name | Not Available | ||||||||||||
| Traditional Name | Not Available | ||||||||||||
| CAS Registry Number | Not Available | ||||||||||||
| SMILES | Not Available | ||||||||||||
| InChI Identifier | Not Available | ||||||||||||
| InChI Key | DMHADBQKVWXPPM-HPKGDXISNA-N | ||||||||||||
| Chemical Taxonomy | |||||||||||||
| Functional Ontology | |||||||||||||
| Not Available | |||||||||||||
| Physical Properties | |||||||||||||
| State | Not Available | ||||||||||||
| Predicted Properties | Not Available | ||||||||||||
| Spectra | |||||||||||||
| Not Available | |||||||||||||
| Biological Properties | |||||||||||||
| Cellular Locations | Not Available | ||||||||||||
| Biospecimen Locations | Not Available | ||||||||||||
| Tissue Locations | Not Available | ||||||||||||
| Associated OMIM IDs | |||||||||||||
| Human Proteins and Enzymes | |||||||||||||
| |||||||||||||
| Human Pathways | |||||||||||||
| Pathways |
| ||||||||||||
| Microbial Pathways | |||||||||||||
| Pathways | This table shows at most 5 pathways. For the full list of associated pathways: See All Associated Bacterial Pathways
| ||||||||||||
| Metabolic Reactions | |||||||||||||
Reactions This table shows at most 20 reactions. For the full list of associated reactions: See All Associated Reactions
| |||||||||||||
| Health Effects and Bioactivity | |||||||||||||
| |||||||||||||
| Microbial Sources | |||||||||||||
| |||||||||||||
| Exposure Sources | |||||||||||||
| Other Exposures |
| ||||||||||||
| Host Biospecimen and Location | |||||||||||||
| |||||||||||||
| External Links | |||||||||||||
| CMMC Knowledgebase | DMHADBQKVWXPPM-HPKGDXISSA-N | ||||||||||||
| References | |||||||||||||
| Synthesis Reference | Not Available | ||||||||||||
| General References |
| ||||||||||||
